ASCENT, RegenXBio’s Phase III clinical trial conducted in partnership with AbbVie, is expected to enroll patients in the United States and Canada, with pivotal trials expected to support BLA submission for RGX-314 in 2024.

Dr. Kerry Gelb speaks with Dr. Jay M. Hainie in the second part of their discussion on diabetes of the eye!

Electronic health records may be the future of practice management.

The 25th annual event was originally scheduled for January 16-19.

Exciting news from OYE Technology!

Clark Chang, OD, MSA, MSc, FAAO, shares why he wish he'd known more about the versatility of the optometric field before starting out in the optometric field.

One doctor's experience leads to key takeaways in ensuring quality care for all patients.

Marc R. Bloomenstein OD, FAAO, and Mile Brujic, OD, FAAO, share the key takeaways from their presentations at EyeCon ’21.

Two EyeCon ’21 faculty panelists highlight their presentation, “Visions of the Future: Contact Lenses of Today and Tomorrow.”

An increase in popularity of the use of handheld electronics is resulting in changes in the postural and behavioral patterns of device users, as well as significant differences between presbyopes and non-presbyopes and between genders.

See our latest poll results

In-person event inspires excellence in eye care

Disrupted vaccination routines in children to blame

From the Chief Optometric Editor

There was no increased risk of having a stroke, myocardial infarction, or pulmonary embolism.

This poll is for optometrists and eyecare professionals, only. It will close on Friday, December 17, 2021.

The panel aims to improve patient care amongst the fastest growing minority demographics within the eye care industry.

The wearable device brings virtual and augmented reality into diagnostics